Data gathered: May 17
Alternative Data for Madrigal Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 29 | Sign up | Sign up | Sign up |
| Sentiment | 95 | Sign up | Sign up | Sign up |
| Webpage traffic | 39,000 | Sign up | Sign up | Sign up |
| Employee Rating | 100 | Sign up | Sign up | Sign up |
| Google Trends | 4 | Sign up | Sign up | Sign up |
| Patents | 23 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | N/A | Sign up | Sign up | Sign up |
| Facebook Followers | 19 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 6,224 | Sign up | Sign up | Sign up |
| Twitter Followers | 1,361 | Sign up | Sign up | Sign up |
| Twitter Mentions | 43 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 101 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 100 | Sign up | Sign up | Sign up |
| Linkedin Employees | 442 | Sign up | Sign up | Sign up |
About Madrigal Pharmaceuticals
Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of non-alcoholic steatohepatitis (NASH) in the United States.
| Price | $217.17 |
| Target Price | Sign up |
| Volume | 235,180 |
| Market Cap | $4.51B |
| Year Range | $120.4 - $283.23 |
| Dividend Yield | 0% |
| Revenue per Employee | $0 |
| Industry | Biotechnology |
In the news
 |
John Paulson's Strategic Moves in Q1 2024 Highlight Madrigal Pharmaceuticals' Prominent RoleMay 15 - Yahoo |
 |
FY2028 EPS Estimates for Madrigal Pharmaceuticals, Inc. Lowered by Analyst (NASDAQ:MDGL)May 14 - ETF Daily News |
Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), Akero Therapeutics (AKRO) and Madrigal Pharmaceuticals (MDGL)May 12 - TipRanks |
|
 |
Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target Cut to $381.00May 11 - ETF Daily News |
|
Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Lowered to $390.00 at HC WainwrightMay 11 - ETF Daily News |
|
Madrigal Pharmaceuticals (NASDAQ:MDGL) PT Lowered to $382.00 at CitigroupMay 11 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 0 | 81M | -81M | -148M | 0 | -7.380 |
| Q4 '23 | 0 | 47M | -47M | -112M | -117M | -5.680 |
| Q3 '23 | 0 | 28M | -31M | -99M | -99M | -5.340 |
| Q2 '23 | 0 | 18M | -21M | -86M | -83M | -4.690 |
| Q1 '23 | 0 | 16M | -19M | -77M | -74M | -4.230 |
Insider Transactions View All
| Taub Rebecca filed to sell 458,999 shares at $248.6. April 10 '24 |
| Taub Rebecca filed to sell 461,451 shares at $243.2. April 10 '24 |
| Taub Rebecca filed to sell 460,206 shares at $245.7. April 10 '24 |
| Taub Rebecca filed to sell 459,199 shares at $247.8. April 10 '24 |
| Taub Rebecca filed to sell 459,606 shares at $247. April 10 '24 |
Similar companies
Read more about Madrigal Pharmaceuticals (MDGL) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Madrigal Pharmaceuticals?
The Market Cap of Madrigal Pharmaceuticals is $4.51B.
How Many People Work at Madrigal Pharmaceuticals?
As of our latest update, Madrigal Pharmaceuticals employed approximately 71 people worldwide. However, it's important to note that Madrigal Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Madrigal Pharmaceuticals' revenue per employee?
$0. To calculate Madrigal Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Madrigal Pharmaceuticals?
Currently, the price of one share of Madrigal Pharmaceuticals stock is $217.17.
How can I analyze the MDGL stock price chart for investment decisions?
The MDGL stock price chart above provides a comprehensive visual representation of Madrigal Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Madrigal Pharmaceuticals shares. Our platform offers an up-to-date MDGL stock price chart, along with technical data analysis and alternative data insights.
Does MDGL offer dividends to its shareholders?
As of our latest update, Madrigal Pharmaceuticals (MDGL) does not offer dividends to its shareholders. Investors interested in Madrigal Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Madrigal Pharmaceuticals?
Some of the similar stocks of Madrigal Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.